W., MARK SLEEMAN,VIKTORIA GUSAROVA,JEE H. KIM,GANG CHEN
申请号：
PT10798240
公开号：
PT2516466T
申请日:
2010.12.23
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
A fully human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human angiopoietin-like protein 4 (hANGPTL4) is provided. The human anti-hANGPTL4 antibodies are useful in treating diseases or disorders associated with ANGPTL4, such as hyperlipidemia, hyperlipoproteinemia and dyslipidemia, including hypertriglyceridemia, hypercholesterolemia, chylomicronemia, and so forth. Furthermore, the anti-hANGPTL4 antibodies can be administered to a subject in need thereof to prevent or treat diseases or disorders, for which abnormal lipid metabolism is a risk factor. Such diseases or disorders include cardiovascular diseases, such as atherosclerosis and coronary artery diseases acute pancreatitis nonalcoholic steatohepatitis (NASH) diabetes obesity and the like.
